Zoetis Inc. Form 13F Holdings: Bonds and Notes
The company's notes and bonds as institutional managers listed them on Form 13F, by quarter and CUSIP. Most corporate bonds are not 13F securities, so few managers report them. Class, amount and value are as filed.
- 2025-12-31: CUSIP 98978VAY9; Class as filed CONVERTIBLE BOND; Managers 1; Principal or shares as filed 23,000,000.
| Quarter end | CUSIP | Class as filed | Managers | Principal or shares as filed | Value (USD) |
|---|---|---|---|---|---|
| 2025-12-31 | 98978VAY9 | CONVERTIBLE BOND | 1 | 23,000,000 | $23,601,818.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |